Astellas Pharma (United States)
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.. Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Astellas Pharma (United States), United States, covering academic research published from 2000 to 2025. Read More.
Open Access Percentage
56%
Total
Publications
2K
Total Open
Publications
1.1K
Total
Citations
66K
Open Access
Percentage
56%
Total
Publications
2K
Total Open
Publications
1.1K
Total
Citations
66K
Breakdown
Publisher Open
23%
Both
29%
Other Platform Open
4%
Closed
44%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 27%
283
Hybrid 39%
405
No Guarantees 34%
350
Other Platform Open
Domain 88%
584
Institution 40%
264
Other Internet 7%
47
Public 2%
15
Preprint 1%
6
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 594 |
doaj.org OAI-PMH Repository | Institution | 138 |
DOI | Other Internet | 25 |
Unknown Repository | Other Internet | 23 |
Europe PMC | Domain | 23 |
Figshare | Public | 15 |
California Digital Library | Institution | 15 |
kuleuven.be OAI-PMH Repository | Institution | 13 |
University of Southern Denmark | Institution | 11 |
Indiana University | Institution | 10 |